Cargando…
Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations
BACKGROUND: The ongoing SARS-CoV-2 pandemic presents a unique challenge to diagnostic laboratories. There are preliminary studies correlating qRT-PCR results from different materials to clinical outcomes, yet, comparability is limited due to the plethora of different assays used for diagnostics. In...
Autores principales: | Nörz, Dominik, Frontzek, André, Eigner, Ulrich, Oestereich, Lisa, Wichmann, Dominic, Kluge, Stefan, Fischer, Nicole, Aepfelbacher, Martin, Pfefferle, Susanne, Lütgehetmann, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510425/ https://www.ncbi.nlm.nih.gov/pubmed/33011643 http://dx.doi.org/10.1016/j.jcv.2020.104650 |
Ejemplares similares
-
Trichomonas vaginalis Detection in Female Specimens with cobas(®) TV/MG for use on the cobas(®) 6800/8800 Systems
por: Marlowe, Elizabeth M., et al.
Publicado: (2019) -
Multisite Performance Evaluation of the cobas 5800 System and Comparison to the cobas 6800/8800 Systems for Quantitative Measurement of HBV, HCV, and HIV-1 Viral Load
por: Tschäpe, Jakob, et al.
Publicado: (2022) -
Clinical establishment of a laboratory developed quantitative HDV PCR assay on the cobas6800 high-throughput system
por: Pflüger, Lisa Sophie, et al.
Publicado: (2021) -
Evaluation of the Performance of the Cobas CT/NG Test for Use on the Cobas 6800/8800 Systems for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Male and Female Urogenital Samples
por: Van Der Pol, Barbara, et al.
Publicado: (2019) -
566. Development of a Prototype Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus complex (CRABC) Assay for use on the cobas® 5800/6800/8800 System Utility Channel
por: Sorenson, Natacha Martins, et al.
Publicado: (2023)